Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × Fluorescein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Melanoma 2 Stomach Neoplasms 1 Skin Neoplasms 1 Neuroma, Acoustic 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Diseases 1 Endometrial Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 50 Bevacizumab 42 Radiotherapy 28 Radiosurgery 18 Carboplatin 14 Erlotinib Hydrochloride 10 Radiation 9 pembrolizumab 8 Vorinostat 8 Magnetic Resonance Spectroscopy 8 Irinotecan 8 Trastuzumab 7 Radiotherapy, Intensity-Modulated 7 Etoposide 7 Capecitabine 7 Lomustine 6 Lapatinib 6 dabrafenib 5 Sunitinib 5 Sorafenib 5 Ipilimumab 5 Imatinib Mesylate 5 Everolimus 5 Cyclophosphamide 5 cabozantinib 4 binimetinib 4 Therapeutics 4 Radiotherapy, Conformal 4 NVP-BKM120 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02028325 2016-11-08

Fluorescein

Indiana University

Phase 4 Terminated

136 enrolled 4 charts

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡